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Summary 
The decision to release a new transgenic crop variety for planting in the European Union is 
a decision under irreversibility and uncertainty. We use a real option model to assess the 
ex-ante incremental benefits and costs of the decision to release Bt maize and HT-maize in 
the EU-15 member states. The analysis uses Eurostat data for modeling the benefits and 
costs of non-transgenic maize using partial equilibrium models. The farm level benefits 
and costs of Bt maize and HT maize are derived from field trials conducted within the EU- 
funded ECOGEN project in combination with secondary data sources. Adoption curves, 
hurdle rates, and maximum incremental social tolerable irreversible costs (MISTICs) are 
calculated at country level for selected EU-15 member states. In general, the results show 
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that the MISTICs on a per capita level are very small confirming previous results 
calculated in values for the year 1995. The MISTICs per farm are much larger. This 
indicates a problem for decision makers. 
  
Introduction 
Despite several concerns, transgenic crops have been introduced and rapidly adopted in 
the United States and other countries (James, 2004). Several studies confirm that on 
average the gross margin per area from transgenic crops is at least as high as, and 
sometimes higher than, that of non-transgenic crops. However, there seems to be a regional 
difference in the distribution of benefits, which are correlated with regional factors like 
pest infestation levels and climatic conditions. Empirical studies also indicate that the 
amount of pesticides may decrease, but only in specific regions and in specific years. 
(Carpenter and Gianessi, 1999; Fernandez-Cornejo et al., 1999; Fulton and Keyowski, 
1999; Scatasta et al., 2006a). Wesseler (2005) provides a detailed background on the 
environmental effects of transgenic crops. 
Rapid adoption of transgenic crops by farmers has been explained by the greater 
benefits farmers gain from planting transgenic crops. Variable production costs are 
reduced, due to reduced pest management and labour. Gross revenues increase due to an 
increase in yield from improved plant spacing. Additional benefits arise from improved 
risk management and insurance against pests and a reduction in equipment costs in no-
tillage production systems (Kalaitzandonakes, 1999). All these are reversible benefits at 
the farm level (i.e., the effects would stop as soon as the transgenic crop is no longer 
planted and do not carry over into subsequent years). Decision makers are particularly 
concerned about the irreversible costs of planting transgenic crops (i.e. effects that would 
still be evident even after the crop is no longer planted). Gene flow and non-target effects 
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can be considered as irreversible costs as they have to be paid for in addition to the costs 
that can be recovered if the planting of the transgenic crop stops (Kendall et al., 1997; 
Krimsky and Wrubel, 1996; Kuiper et al., 2000; Nillesen et al., 2006a; Peterson et al., 
2006). The decrease in pesticide use by planting transgenic crops and Bt crops (i.e. crops 
expressing an insecticidal protein from Bacillus thuringiensis) in particular not only 
reduces farmers' expenses but also provides additional benefits, since the application of 
pesticides may have negative impacts on the environment and human health (Antle and 
Pingali, 1994; Waibel and Fleischer, 1998; Fleischer, 1998). Most of these external costs 
of pesticide application are irreversible.  
One could perhaps think of reversing some of the irreversible effects such as on 
biodiversity or pest resistance, however, even if that were possible it would not be costless 
and Demont et al. (2005) show an irreversibility effect could still exist. 
The possibility of irreversible costs with the introduction of transgenic crops into the 
European Union (EU) was one of the major arguments for some of the EU member states 
to block new approvals of genetically modified organisms (GMOs) until the European 
Commission proposed additional legislation governing their introduction (Commission of 
the European Communities, 1999). The decision became to be known as the quasi 
moratorium on GMOs. 
The irreversible effects of transgenic crops, and the uncertainty about their future costs 
and benefits, will impact when and if they will be released. Both irreversible costs and 
uncertainty and their impact on optimal investment have been widely analysed (e.g. 
McDonald and Siegel, 1986; Dixit and Pindyck, 1994; Trigeorgis, 1996). Recently, the 
approach has been applied, among other things, to the adoption of soil conservation 
measures (Winter-Nelson and Amegbetto, 1998), marketing (Richards and Green, 2003), 
wilderness preservation (Conrad, 2000), agricultural labour migration (Richards and 
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Patterson, 1998), the introduction of herbicide-tolerant sugar beets in the EU (Demont et 
al. 2004) and the analysis of government reforms (Leitzel and Weisman, 1999). In the case 
of transgenic crops there are the additional irreversible government policy costs of  the 
implementation of biosafety regulations and changes in patent laws. As they may be of 
importance, we will concentrate in this paper on the crop related irreversibilities. 
The objective of this paper is to present economic benefits and costs for pest resistant 
(Bt) maize and herbicide tolerant (HT) maize and to identify, ex-ante, potential social 
welfare impacts of adoption of Bt maize and HT maize for grain maize production in the 
15 member states of the EU (EU-15). A model will be presented that shows how those 
concerns can be considered explicitly by using the concept of Maximum Incremental 
Social Tolerable Irreversible Costs (MISTICs).  
 
Materials and Methods 
Methodological approach to assess the benefits and costs of transgenic crops 
Consider a decision maker or a decision-making body similar to an EU agency, such as 
the European Food Safety Authority (EFSA) or the United States Environmental 
Protection Agency (US-EPA), that has the authority to decide whether or not a particular 
transgenic crop, e.g. a toxin-producing crop like Bt maize, should be released for 
commercial planting. The agency can approve an application for release or postpone the 
decision and wait to up-date the information about possible benefits and costs of the 
technology. The objective of the agency is to maximize the welfare of producers and 
consumers in the economy while ignoring positive and negative transboundary effects. 
Within this setting the welfare effect of releasing a specific transgenic crop can be 
described as the discounted sum from T till infinity of the social incremental reversible net 
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benefits, W, minus the difference between incremental irreversible costs, I, and incremental 
irreversible benefits, R, of the technology. 
As the agency has the possibility to postpone the decision on whether or not to release 
the transgenic crop, the agency has to maximize the value resulting from this decision, 
F(W), to maximize the welfare. This objective can be described as maximizing the 
expected value from releasing the transgenic crop:  
    max max TT T TF W E W I R e       (1) 
where E is the expectation operator, T the point in time when the transgenic crop is 
released into the environment and ρ the discount rate. T=0 implies an immediate release 
and T>0 postponing the release.  
The welfare effect at farm level is the difference between the sums of gross margins 
from transgenic crops minus the total sum of gross margins from the alternative non-
transgenic crop (termed the conventional crop for the rest of the paper) minus private 
incremental irreversible investment costs plus incremental irreversible benefits (Weaver 
and Wesseler, 2005). The welfare benefits of Bt grain maize and HT grain maize can be 
modelled for EU-15 member states by using a small open economy model. Potential 
welfare losses (deadweight losses) of EU agricultural policy will not be considered, as the 
EU policy is seen as the efficient outcome of different pressure groups lobbying for 
policies. The private incremental reversible net-benefit in a given year is then the 
difference in gross margin on a hectare basis between the transgenic and the conventional 
crop times the area planted with the transgenic crop. As we do not consider changes in 
administration costs and spill-over effects, the private incremental reversible benefits are 
equal to the social incremental reversible benefits of introducing the Bt maize and HT 
maize, respectively. 
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The area allocated over time to planting transgenic crops can be expected to increase 
following a logistic adoption pattern (Demont et al, 2004). Consequently, the annual social 
incremental reversible benefits increase over time as well. For comparison of future and 
present social incremental reversible benefits, future social incremental reversible benefits 
will be discounted. The total social incremental reversible benefit of introducing Bt maize 
or HT maize is the sum of the annual incremental reversible benefits per hectare times the 
area allocated to the crop, in this case grain maize, times the adoption rate over an infinite 
period of time:  
max ( ) ( )
t
T T
W W t t e dt    (2) 
where the subscript max indicates values at complete adoption and t represents time,  , the 
rate of adoption of the new technology and   the risk-adjusted discount rate. 
Similarly, the social incremental irreversible benefits of introducing transgenic grain 
maize are max ( ) ( )
t
T T
R R t t e dt   . 
Under the assumption that the social incremental reversible benefits follow a continuous 
time continuous state process (Wesseler, 2003) Bt maize and HT maize should be released 
at the point in time, where the current social incremental reversible benefits WT are greater 
than the difference between the social incremental irreversible costs (IT) and the social 
incremental irreversible benefits (RT) weighted by the size of the uncertainty and flexibility 
associated to the adoption of a new technology (or hurdle rate). The hurdle rate is 
commonly expressed in the form  1   , where 1   captures the combined 
flexibility, irreversibility and uncertainty effect (Demont et al., 2004). A hurdle rate of, 
e.g., 1.7 implies the incremental benefit of the new technology has to be at least 1.7 times 
the net irreversible costs to be considered more beneficial than the best alternative 
technology available. 
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As long as the social incremental reversible benefits, WT, are less than the social 
incremental net-irreversible costs, (IT-RT), weighted by the hurdle rate, 
  1T T TW I R    , the EU should delay introduction of the transgenic crop under 
consideration until more information about benefits and costs of the new technology is 
available. 
In the context of transgenic crops where people are more concerned about the uncertain 
irreversible costs of the technology, threshold values that indicate the maximum 
incremental social irreversible costs that an individual or society in general is willing to 
tolerate for the sake of the benefits of the technology can provide useful information. We 
have called this value (Scatasta et al., 2006b) the Maximum Incremental Social Tolerable 
Irreversible Costs, I*, or MISTICs for short. Actual social incremental irreversible costs, I, 
are to be no greater than the sum of social incremental irreversible benefits and social 
incremental reversible net-benefits from transgenic crops, such that: 
 * 1TT T
WI I R      (3) 
The formulation of the MISTICs, I*, illustrates the effect of waiting due to combined 
flexibility, irreversibility, and uncertainty. The total benefits of introducing transgenic 
crops are the sum of the social incremental irreversible benefits and the social incremental 
reversible net-benefits, without explicitly recognizing flexibility (the possibility to 
postpone the decision), irreversibility, and uncertainty. However, when considering 
flexibility, irreversibility, and uncertainty only a proportion of the social incremental 
reversible benefits, 1
1

   should be taken into account. The proportion 1 1 1


     in 
this context can be interpreted as the economic value of irreversibility and uncertainty 
under flexibility of releasing transgenic crops. The MISTICs can be summarized as the 
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threshold values below which the irreversible costs have to be for the GM crop to be 
economically better. 
 
Quantifying social incremental reversible net-benefits (SIRBs) from Bt maize and HT 
maize 
Social incremental reversible net-benefits in this study include private incremental 
reversible net-benefits for two market agents: buyers and sellers. We limit the analysis to 
two types of technologies, transgenic and conventional, without taking organic production 
into consideration (see Klotz-Ingram et al., 1999; Traxler and Falck-Zepeda, 1999; Pray et 
al., 2001; Frisvold et al., 2003; Demont and Tollens, 2004; Demont et al., 2004). 
As mentioned earlier the EU member states are small open economies with respect to 
grain maize, facing a horizontal demand curve. Following Moschini et al. (2000), social 
incremental reversible net-benefits are measured in terms of producer surplus derived from 
constant elasticity log-linear supply functions. The degree to which the price for grain 
maize changes with an increase grain maize supply, the supply elasticity, was taken from 
the European Simulation Model (ESIM) where the change is derived from behavioural 
equations. The suggested elasticity for land allocation to maize is 0.77, so we approximate 
the supply elasticity to this value in our base case (see Banse et al., 2004). The introduction 
of a technological innovation, such as Bt maize, causes a pivotal shift in the inverse supply 
function. This shift for a maximum adoption of hundred per cent is calculated as: 
 
1/ 1/
max
1/
1 1
1
gc
c gc g
c
c c
VCVC
y yy y
K
VC
y y
 

               
 (4) 
where cVC  are variable operating costs in Euro per hectare associated with the 
conventional technology; gVC  are variable operating costs (Euro per hectare) associated 
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with the transgenic technology; cy  is production (in metric tons) under conventional 
technology and gy  is production (in metric tons) under the transgenic technology and  the 
supply elasticity. The expression  i iVC y  is used to approximate marginal costs of 
technology i. Note that if there is no yield gain from planting transgenic maize, the K-shift 
in the supply function reduces to /c g cK VC VC VC     as assumed for the case of HT 
maize. For Bt maize we used data from field trials carried out in Narbons, France in 2004, 
comparing average yield and cost advantages of the commercial variety (Paolis) with the 
Bt variety MON810 and obtain a value of K=0.24. For HT maize we use the values 
reported by Gianessi et al. (2003) and find a K=0.12. Table 1 presents the gross margins 
for Bt maize planted at the Narbons field trial (Andersen et al., 2007) for 2004 and 2005.  
Under our assumptions the social incremental reversible net-benefits from transgenic 
crops are represented by changes in producer surplus (see Scatasta et al., 2006c, unpubl. 
work, for details of the model). These changes are calculated over an infinite time horizon 
and then expressed in annuities multiplying their total present value by the risk-adjusted 
discount rate. All values are expressed in 2004 Euro to control for price changes. 
 
Quantifying social incremental irreversible benefits (SIIBs )from Bt maize and HT 
maize 
Social incremental irreversible benefits (SIIBs) for Bt maize were calculated on the 
basis of changes in pesticide use and fuel use. In the Narbons field trials 0.035 kilogram 
less Active Ingredient (kgAI) insecticide per hectare were used for Bt maize; the numbers 
from Gianessi et al. (2003) result in a reduction in herbicide use for HT maize in the order 
of 1.719 kgAI per hectare. Changes in fuel use are derived from a comparative technology, 
which suggests a reduction of 0.01 tonnes of CO2 emissions per hectare (Demont et al., 
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2004). Following Pretty et al. (2000) we considered 0.69 Euro of social irreversible 
benefits per kgAI reduction and 77.4 Euro of social irreversible benefits per tonne of CO2 
emissions. These values give irreversible benefits per hectare in the amount of 0.73 Euro 
for Bt maize and 1.78 Euro for HT maize (1995 values, the real value in 2004 changes for 
each county depending on the deflator). 
SIIBs are then found summing the value of benefits from reduced insecticide and 
herbicide use per hectare and then multiplying this value by the adopted number of 
hectares. These benefits are calculated over an infinite time horizon and then expressed in 
annuities multiplying their total present value by a risk-adjusted discount rate. All values 
are in 2004 Euro. 
 
Quantifying adoption rates,   
The transgenic maize adoption curve is assumed to follow a logistic pattern over time. 
The size and speed of adoption can be estimated with ordinary least squares (OLS) using 
data from the adoption rates in the United States (James, 2004). Following Demont et al. 
(2004) the speed of adoption is then assumed half of that of the U.S. This allows us to 
obtain conservative estimates of the social incremental reversible benefits. For the sake of 
simplicity, transparency and comparison between Member States, we opt for an exogenous 
adoption curve and assume an adoption ceiling of 30% for Bt maize and 40% for HT 
maize. We obtain: 
 ( )ln 2.41 0.335
0.3 ( ) Bt
t t
t


       Bt maize  (5a.) 
 ( )ln 2.15 0.187
0.3 ( ) Ht
t t
t


       HT maize  (5b) 
where ( )t represents maize adoption rate. For a discussion about adoption rate for Bt 
maize in Europe depending on ECB pressure consult Nillesen et al. (2006b, unpubl. work). 
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As the speed of transgenic maize adoption is probably important in determining the gains 
the EU will enjoy from this technology, we take its 95% confidence interval into 
consideration and allow this parameter to vary between half of the lower bound of this 
interval (0.14 for Bt and 0 for HT) and the full upper bound of the confidence interval 
(1.06 for Bt and 0.40 for HT), assigning this parameter a pert distribution with mode 0.335 
for Bt maize and 0.187 for HT maize. Results for each scenario represent mean results of 
5000 iterations on the simulated speed of adoption. The simulation software used is 
RiskAmp. 
 
Quantifying maximum incremental social tolerable irreversible costs (MISTICs) 
The MISTICs were computed as in equation (1) for 2004. The parameter values for 
identifying the hurdle rates are estimated from gross margin time series data provided by 
EUROSTAT (http://europa.eu.int/newcronos) following Demont et al. (2004). Following 
expert opinions on corn borer infestation levels we analyzed for Bt maize in five countries: 
France, Italy, Spain, Portugal and Greece. We considered for HT maize nine countries: 
France, Italy, Spain, Portugal, Greece, Austria, Belgium, The Netherlands and Germany. 
We performed the analysis using a risk-adjusted discount rate of 10.5% as in Demont, 
Wesseler and Tollens (2004). We calculated the producer surplus 1) at quantities for prices 
excluding subsidies (called producer prices in the database) and 2) at quantities for prices 
including subsidies (called basic prices in the EUROSTAT database).  
 
Results and Discussion 
Tables 2 and 3 show the social incremental reversible as well as irreversible benefits 
and costs for introducing Bt maize and HT maize for grain maize production in selected 
countries of the EU-15. The first two columns show the calculated average annual social 
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incremental reversible benefits. Those benefits are enormous. They are about 62 million 
Euros on average per year for France in the case of Bt maize with CAP subsidies and about 
36 million Euros per year in the case of Bt maize without CAP subsidies. Nevertheless, the 
SIRBs are about 29 million Euros per year in the case with CAP subsidies and about 17 
million Euros per year in the case without subsidies. In general, HT maize offers lower 
potential gains than Bt maize. Without CAP subsidies potential gains are reduced by about 
40-50%. This is simply due to the absence of the subsidies as a revenue component and 
indicates the land allocation effect of the CAP subsidy. 
The SIIBs are very small. For France they reach about 240,000 Euro on average per 
year for Bt maize. In general, they are about one Euro per hectare and year for the five 
countries considered for Bt maize. The social incremental irreversible benefits are slightly 
larger for HT maize mainly because of larger savings in CO2 emissions.  
The sum of the SIRBs and the SIIBs can be seen as the average benefits per year 
foregone by postponing the introduction of Bt maize (HT maize) for another year. Take the 
case of France. France foregoes about 29 million Euros per year for postponing the 
introduction of HT maize and about 62 million Euro per year for postponing the 
introduction of Bt maize for grain maize production. 
The hurdle rates indicate the percentage of compensation in the form of social 
incremental reversible plus irreversible benefits for one Euro of incremental irreversible 
costs. The hurdle rates are highest for Belgium followed by The Netherlands. The case for 
Belgium needs to be considered with care because of the database. The example for The 
Netherlands indicates that one Euro of incremental irreversible costs needs to be 
compensated by about 5.50 Euro of social incremental reversible plus irreversible benefits 
and shows more then one unit of reversible benefits is needed to compensate for one unit 
of irreversible costs. The comparison of the situation with and without the CAP is mixed. 
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For some countries the hurdle rates increase (Austria, Belgium, France, Greece, and Italy) 
while for others the hurdle rates decrease (Germany, Netherlands, Portugal, and Spain). 
The higher the hurdle rates are, the lower the MISTICs will be (see equation 3). The 
MISTICs are the threshold values below which the irreversible costs have to be for the GM 
to be economically profitable. The MISTICs in million Euros per year range from about 2 
million Euro per year for Portugal to up to 54 million Euro per year for France for the case 
of Bt maize. As expected the values for HT maize are lower. They range from about 20 
thousand Euro per year for Belgium to up to 26 million Euros per year for France.  
The important question is whether or not actual incremental irreversible costs will 
exceed the MISTICs. The irreversible cost of pesticide use provides some insights. Bt 
maize and HT maize are approaches to control insect pests and weeds and have similar 
implications for the environment and human health as pesticides themselves. A comparison 
between the social incremental irreversible benefits and the MISTICs shows that the 
MISTICs are higher than the SIIBs by a factor of two for Belgium and at least by a factor 
12 for the other countries in the case of HT maize. For the case of Bt maize the MISTICs 
for each country are at least by a factor of 72 higher than the SIIB. These high factors cast 
doubts about the actual social incremental irreversible costs being as high as the MISTICs. 
The results provide a good argument for immediately introducing Bt maize and HT maize 
into the countries included in Tables 2 and 3.  
The picture changes if the MISTICs are calculated on a per capita level. In that case the 
MISTICs are very small. For all countries and all cases considered the MISTICs are below 
one Euro a year. The results by Chern et al. (2003) support the expectation that consumers’ 
willingness-to-pay for Bt maize and HT maize is more than one Euro per year. In our 
model, all benefits from the introduction of transgenic maize accrue to a small group of 
maize farmers. Distributing the total MISTICs among this small group generates higher 
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MISTIC than distributing them among all European citizens as indicated in the last column 
in Tables 2 and 3. 
The results of the sensitivity analysis for the speed of adoption and a lower k-shift (0.16 
for Bt-maize and 0.06 for HT maize) do not change the main conclusions (results available 
upon request from the authors). 
 
Conclusions 
The use of the real option approach to value the economic benefits and costs of 
introducing Bt maize and HT maize considers potential irreversible costs of the 
introduction explicitly. Using the real option approach demonstrates that it is possible to 
consider long-term effects of GM crops in an economic analysis. Those concerns are 
captured by the Maximum Incremental Social Tolerable Irreversible Costs or MISTICs for 
short of introducing Bt maize and HT maize for grain maize production in the EU-15. 
The results quantify the decision makers’ dilemma: on the one hand there are good 
economic reasons for introducing Bt maize and HT maize immediately, if one analyzes at 
the national economy and farmholder scale, but on the other hand there are good reasons 
for postponing the decision considering the low MISTICs per capita. This indicates the 
introduction of Bt maize and HT maize does not increase the welfare of all citizens or in 
economic terms is a Pareto improvement.  
The EU has addressed concerns of citizens by introducing a labelling and tracking and 
tracing system for GMOs, as well as coexistence rules governing the planting of transgenic 
crops. Those policies can be seen as a compensation for those citizens that are concerned 
about introduction of transgenic crops. From that perspective the decision by the European 
Commission to postpone further approvals of GM crops until labelling and tracking 
systems for GMOs are in place and coexistence rules established can be considered a wise 
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decision albeit this decision came at high economic costs. Spain that introduced Bt maize 
early, about five years ago, gained about 135 million Euros, while France, e.g., forwent 
economic gains of about 310 million Euros over the same period, ceteris paribus.  
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